{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for nonoxynol root_notes_@count in root_notes_@count (approximate match)
Status:
US Approved Rx
(2022)
Source:
BLA761268
(2022)
Source URL:
First approved in 2004
Source:
BLA125085
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2002)
Source:
BLA125019
(2002)
Source URL:
First approved in 2002
Source:
BLA125019
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
USAN:GEMIBOTULINUMTOXIN A [USAN]
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT03051516: Phase 4 Interventional Terminated High Grade Anal Canal Intraepithelial Neoplasia
(2017)
Source URL:
First approved in 2006
Source:
BLA125126
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT03051516: Phase 4 Interventional Terminated High Grade Anal Canal Intraepithelial Neoplasia
(2017)
Source URL:
First approved in 2006
Source:
BLA125126
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
POLYMER
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
POLYMER
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
POLYMER
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
POLYMER